Strengthening HIV Clinical Services within a Network of Public and Private Health Institutions in the West, South, and North West Departments of Haiti under the President’s Emergency Plan for AIDS Relief (PEPFAR) | Apply Online

Frequently Asked Questions (FAQs)

1) What is the title of this funding opportunity?

The opportunity is titled "Strengthening HIV Clinical Services within a Network of Public and Private Health Institutions in the West, South, and North West Departments of Haiti under the President's Emergency Plan for AIDS Relief (PEPFAR)."

2) What type of funding mechanism is being offered?

This opportunity is a U.S. government cooperative agreement.

3) What does it mean that this award is a cooperative agreement?

Because it is a cooperative agreement, the CDC is expected to have substantial involvement in implementation. Based on the summary provided, this can include collaboration on technical approaches, monitoring, and performance improvement, rather than a more hands-off grant model.

4) Which U.S. agency is issuing this opportunity?

The opportunity is issued by the U.S. Centers for Disease Control and Prevention (CDC) within the Department of Health and Human Services (HHS).

5) Is this opportunity connected to PEPFAR?

Yes. The program sits under the President's Emergency Plan for AIDS Relief (PEPFAR).

6) What is the main purpose of the program?

The core purpose is to sustain continuity and strengthen clinical HIV and tuberculosis (TB) services in Haiti by building on existing platforms, maintaining access to lifesaving care, and improving quality and coverage.

7) What geographic areas in Haiti are targeted?

The work focuses on Haiti's West, South, and North West departments.

8) How is service delivery organized under this program?

The program is structured around three networks of public health institutions spanning the West, South, and North West departments of Haiti, with an emphasis on coordinated service delivery across multiple facilities rather than stand-alone sites.

9) Are private institutions included, or only public institutions?

The opportunity specifically describes a network of public and private health institutions.

10) What clinical HIV services are emphasized?

The summary highlights three main clinical objectives: (1) delivering high-quality HIV testing and counseling (HTC) and prevention of mother-to-child transmission (PMTCT) services, (2) providing comprehensive HIV care and treatment for pediatric and adult patients, and (3) supporting a full spectrum of TB services, including prevention, diagnosis, and treatment.

11) Does the opportunity include HIV testing and counseling (HTC)?

Yes. Delivering high-quality HIV testing and counseling (HTC) is one of the stated service objectives.

12) Does the opportunity include prevention of mother-to-child transmission (PMTCT)?

Yes. PMTCT is specifically named as a key service objective.

13) Does the opportunity support HIV treatment for both adults and children?

Yes. The summary states comprehensive HIV care and treatment for both pediatric and adult patients.

14) Is tuberculosis (TB) included in the scope, and if so, how?

Yes. The program supports a full spectrum of TB services, including TB prevention, diagnosis, and treatment, reflecting TB's role as a major co-infection risk and cause of illness and death among people with HIV.

15) What outcomes is the program aiming to achieve?

The FOA is described as aiming to reduce new HIV infections, improve health outcomes for people living with HIV, prevent HIV transmission from mothers to infants, and address TB as a major co-infection risk.

16) What funding activity area does this opportunity fall under?

The opportunity is categorized under the health funding activity area.

17) Is this a discretionary funding opportunity?

Yes. The summary categorizes it as discretionary.

18) What is the CFDA number associated with this opportunity?

The CFDA number listed is 93.067, associated with CDC HIV-related assistance.

19) Who is eligible to apply?

Eligibility is listed as "Others," with additional eligibility details referenced in the full announcement text. This suggests the applicant type is not limited to a single standard category in the summary field and may include a range of organizations depending on CDC's criteria in the full announcement.

20) How many awards does CDC expect to make?

The announcement indicates an expected single award.

21) What is the maximum funding amount (award ceiling)?

The award ceiling is $6,000,000.

22) What does an expected single award imply about implementation?

Based on the summary, a single award suggests CDC intended to fund one principal implementing partner to lead or coordinate the supported networks and ensure consistent clinical programming across the targeted departments.

23) When was the opportunity posted?

The timeline states the funding opportunity was created and posted on December 8, 2015.

24) What was the application closing date?

The application closing date was February 8, 2016.

25) How much time was available to apply based on the dates provided?

Based on the posting date (December 8, 2015) and closing date (February 8, 2016), applicants had roughly two months to prepare and submit proposals.

26) Is this opportunity focused more on starting new sites or strengthening existing services?

The summary emphasizes continuity and strengthening of services, meaning the award is intended to build on existing platforms, sustain access to care, and improve quality and coverage rather than focusing solely on creating isolated, stand-alone sites.

27) What is the overall program approach described in the summary?

The FOA is described as a targeted investment to reinforce integrated HIV and TB service delivery in key regions of Haiti through coordinated networks that span public and private institutions, emphasizing the full continuum of HIV services and strong maternal and child health integration via PMTCT.